Mihaela Zidarn
University of Ljubljana
Health careImmunologyAllergyAsthmaMedicine
What is this?
Publications 54
#1Jean BousquetH-Index: 128
#2John FarrellH-Index: 22
Last. J. M. AntoH-Index: 25
view all 122 authors...
#1Katarzyna Niespodziana (Medical University of Vienna)H-Index: 10
#2Kristina Borochova (Medical University of Vienna)
Last. Elena Borzova (RSMU: Russian National Research Medical University)
view all 75 authors...
Abstract Asthma is a severe and chronic disabling disease affecting more than 300 million people world-wide. While in the past few drugs for treatment of asthma were available, new treatment options are currently emerging which appear to be highly effective in certain subgroups of patients. Accordingly there is a need for biomarkers which allow selection of patients for refined and personalized treatment strategies. Recently, serological chip tests based on micro-arrayed allergen molecules and p...
#1Bernardo Sousa-Pinto (University of Porto)H-Index: 6
#2Kimberly G. Blumenthal (Harvard University)H-Index: 18
Last. João Fonseca (University of Porto)H-Index: 33
view all 30 authors...
2 CitationsSource
#1Jean BousquetH-Index: 128
#2Holger J. Schünemann (McMaster University)H-Index: 109
Last. Mihaela ZidarnH-Index: 13
view all 249 authors...
In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system into integrated care with organizational health literacy. As an example for chronic disease care, MASK (Mobile Airways Sentinel NetworK), a new project of the ARIA (Allergic Rhinitis and its Impact on Asthma) initiative, and POLLAR (Impact of Air P...
2 CitationsSource
#1Mihaela Zidarn (University of Ljubljana)H-Index: 13
Last. Peter KoroÿH-Index: 19
view all 10 authors...
#1Mihaela ZidarnH-Index: 13
#2Nissera BajrovićH-Index: 8
Last. Jean BousquetH-Index: 128
view all 28 authors...
The Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a World Health Organization (WHO) workshop in 1999. The initial goals were (i) to propose a new allergic rhinitis classification, (ii) to promote the concept of multi-morbidity in asthma and rhinitis and (iii) to develop guidelines with all stakeholders for global use in all countries and populations. ARIA - disseminated and implemented in over 70 countries globally - is now focusing on the implementation of emergi...
#1Sinthia Bosnic-Anticevich (WIMR: Woolcock Institute of Medical Research)H-Index: 29
#2Elísio Costa (University of Porto)H-Index: 20
Last. Jean BousquetH-Index: 128
view all 122 authors...
Pharmacists are trusted health professionals. Many patients use over-the-counter (OTC) medications and are seen by pharmacists who are the initial point of contact of allergic rhinitis management i ...
5 CitationsSource
#1Jean Bousquet (French Institute of Health and Medical Research)H-Index: 128
#2Peter Hellings (Katholieke Universiteit Leuven)H-Index: 46
Last. A. ZurkuhlenH-Index: 3
view all 540 authors...
Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline by using the best approach to integrated care pathways using mobile technology in patients with allergic rhinitis (AR) and asthma multimorbidity. The proposed next phase of ARIA is change management, with the aim of providing an active and healthy life to patients with rhinitis and to those with asthma multimorbidity across the lifecycle irrespective of their sex or socioeconomic status to reduce health and social ine...
13 CitationsSource
#1Jean BousquetH-Index: 128
#2Holger J. SchünemannH-Index: 109
Last. Mihaela ZidarnH-Index: 13
view all 249 authors...